Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 22.69 | 7.82 |
| PEG Ratio (TTM) | -0.72 | -2.82 |
| P/S Ratio (TTM) | 0.58 | 3.15 |
| P/B Ratio (TTM) | 0.78 | 2.11 |
| P/FCF Ratio (TTM) | 5.27 | 20.18 |
| Price to 5YR AVG Earnings Ratio | N/A | 19.68 |
| Price to 5YR AVG FCF Ratio | N/A | 24.81 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.33% | 2.68% |
| ROE (TTM) | 3.48% | 13.88% |
| Net Profit Margin (TTM) | 2.55% | -37.53% |
| ROIC 5YR AVG | N/A | 0.29% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 118.59% | 3,349.65% | N/A |
| Revenue | -3.18% | 80.50% | N/A |
| Net Income | 122.99% | 1,892.03% | N/A |
| Cash Flow | -18.68% | 310.44% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.93 | 2.29 |
| Quick Ratio (TTM) | 1.17 | 1.64 |
| D/E Ratio (TTM) | 1.20 | 0.80 |
| Interest Coverage (TTM) | 1.18 | -21.01 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 1.31 | 4.47 |
| LTL to 5YR AVG FCF | N/A | 8.82 |
| Shares Outstanding Growth 5YR AVG | N/A | 14.54% |